
Pfizer Inc.
PFE 25.06 (-2.67%) 0.67
Health Care
Pharmaceuticals
Quality Checklist 3/8
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
5Y Shares Out Change < 0%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $142.48(B)
EV: $189.73(B)
Total Equity: $93.10(B)
Earnings date: Feb-03-2026
P/E: 14.49
Forward P/E: 7.98
P/FCF: 13.77
P/S: 2.27
P/B: 1.54
EPS: $1.7
EPS (fwd): $3.1
FCF/share: $1.8
Revenue/share: $11.1
Book value/share: $16.3
ROIC: 6.3%
ROA: 4.6%
ROE: 10.6%
Debt/Equity: 0.67
Current Ratio: 1.30
Gross margin: 74.8%
Operating margin: 24.6%
Net margin: 15.7%
Dividend/share: $1.7
Div. yield: 6.78%
TTM Financials
Income (TTM)
Revenue$62.78(B)
Gross profit$46.97(B)
EBITDA$24.46(B)
Net income$9.83(B)
Gross margin74.8%
Operating margin24.6%
Net margin15.7%
Shares outstanding5.69(B)
Balance sheet
Total assets$208.73(B)
Current assets$46.92(B)
Total liabilities$115.64(B)
Current liabilities$36.60(B)
Cash & Short-term inv.$14.99(B)
Long-term debt$57.63(B)
Total intangibles$120.42(B)
PP&E$18.88(B)
Cash flow (TTM)
FCF$10.38(B)
CapEx$-2.70(B)
Dividends paid$-9.71(B)
Stock issued$0
Stock repurchased$0
Stock-based comp.$767.00(M)
Debt issued$4.42(B)
Debt repaid$-10.30(B)
